07.30.2019
Prevent & Delay
$1,113,582.00
48 months
From Benign Islet Autoimmunity to Type 1 Diabetes: Mechanistic CD8+ T-Cell Biomarkers of Progression
Funds will support a project at the INSERM to develop an assay capable of detecting T1D autoimmunity.